haemophilia

Views & Analysis

The unmet needs of bleeding disorder patients

Ahead of eyeforpharma Philadelphia 2019, we talk to speaker and haemophilia advocate Michelle Rice about the changing landscape for bleeding disorders

News

EU expands use of Roche's new haemophilia A drug

The European Commission has approved Roche haemophilia A drug Hemlibra for patients without factor VIII inhibitors, expanding the use of the drug that is expected to drive sales as blockbus

News

Gene therapy firm BioMarin stages haemophilia musical

BioMarin Pharmaceutical has put on a stage musical to raise awareness about haemophilia, and determine whether creative expression helps patients, as it develops an experimental cure for th

Views & Analysis

How pharma can boost engagement by embracing support network...

Connecting with patients has become a central plank in the pharma marketing playbook, but should companies be looking for a wider view when looking for insights to inform their branding?

News

Roche's Hemlibra approved in expanded haemophilia A use

Roche’s Hemlibra has been approved in an expanded use in haemophilia A in the US, as the Swiss firm seeks to build a new blockbuster franchise in rare diseases.

News

Sanofi’s rare disease drug Cablivi approved in the EU

The European Commission has approved Sanofi’s Cablivi, the first treatment for patients with the rare blood-clotting disorder, acquired thrombotic thrombocytopenic purpura (aTTP), which is

The unmet needs of bleeding disorder patients

EU expands use of Roche's new haemophilia A drug

Gene therapy firm BioMarin stages haemophilia musical

How pharma can boost engagement by embracing support network...

Roche's Hemlibra approved in expanded haemophilia A use

Sanofi’s rare disease drug Cablivi approved in the EU

Setback for MSD as German court blocks Keytruda SC launch

How to meet your physicians where they are online

haemophilia

Editor's Picks